Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Precigen Inc’s stock clocked out at $3.6, down -4.00% from its previous closing price of $3.75. In other words, the price has decreased by -$4.00 from its previous closing price. On the day, 3.11 million shares were traded. PGEN stock price reached its highest trading level at $3.85 during the session, while it also had its lowest trading level at $3.595.
Ratios:
To gain a deeper understanding of PGEN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.95 and its Current Ratio is at 4.04. In the meantime, Its Debt-to-Equity ratio is 2.35 whereas as Long-Term Debt/Eq ratio is at 2.32.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 19 ’25 when KIRK RANDAL J sold 1,086,153 shares for $4.47 per share. The transaction valued at 4,855,104 led to the insider holds 7,434,384 shares of the business.
KIRK RANDAL J sold 942,832 shares of PGEN for $3,846,755 on Nov 20 ’25. The Director now owns 6,491,552 shares after completing the transaction at $4.08 per share. On Nov 21 ’25, another insider, KIRK RANDAL J, who serves as the Director of the company, sold 937,308 shares for $3.83 each. As a result, the insider received 3,589,890 and left with 5,554,244 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 1273768192 and an Enterprise Value of 1250825216. For the stock, the TTM Price-to-Sale (P/S) ratio is 201.87 while its Price-to-Book (P/B) ratio in mrq is 30.42. Its current Enterprise Value per Revenue stands at 198.26 whereas that against EBITDA is -11.919.
Stock Price History:
The Beta on a monthly basis for PGEN is 1.11, which has changed by 3.5 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, PGEN has reached a high of $5.22, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is -5.36%, while the 200-Day Moving Average is calculated to be 45.20%.
Shares Statistics:
It appears that PGEN traded 5.07M shares on average per day over the past three months and 3236020 shares per day over the past ten days. A total of 353.81M shares are outstanding, with a floating share count of 149.28M. Insiders hold about 57.81% of the company’s shares, while institutions hold 31.65% stake in the company. Shares short for PGEN as of 1763078400 were 28884978 with a Short Ratio of 5.69, compared to 1760486400 on 32041619. Therefore, it implies a Short% of Shares Outstanding of 28884978 and a Short% of Float of 12.629999999999999.
